IL6 and atherosclerosis: Chronic inflammation is also a well-defined non-traditional risk factor in the pathogenesis of atherosclerosis, where cytokines such as interleukin 1 (IL-1), interleukin 6 (IL-6), and TNF-α may promote endothelial dysfunction, which plays a key role in the process of atherogenesis.